Short-term ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjects - A randomized double-blind placebo-controlled crossover study

Clinical Nutrition

Volumn 25, Issue 1, 2006, Pages 123-134

  Kudolo, George B ^a   Wang, Wen ^a   Elrod, Ryan ^a   Barrientos, Jessica ^a   Haase, Alexis ^a   Blodgett, Janet ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Ginkgo biloba; Insulin resistance; Type 2 diabetes

Indexed keywords

GINKGO BILOBA EXTRACT; GLIBENCLAMIDE; GLIPIZIDE; INSULIN; METFORMIN; PLACEBO; ROSIGLITAZONE; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INGESTION; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SINGLE DRUG DOSE; STATISTICAL ANALYSIS;

ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GINKGO BILOBA; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PLANT EXTRACTS;

EID: 33144470037     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2005.10.001     Document Type: Article

References (44)

1. B.S. Oken D.M. Storzbach J.A. Kaye The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease Arch Neurol 55 1998 1409-1415
2. P. Curtis-Prior D. Vere P. Fray Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function J Pharm Pharmacol 51 1999 535-541
3. P.L. Moulton L.N. Boyko J.L. Fitzpatrick T.V. Petros The effect of Ginkgo biloba on memory in healthy male volunteers Physiol Behav 73 2001 659-665
4. J. Kleijnen P. Knipschild Ginkgo biloba for cerebral insufficiency Br J Clin Pharmacol 34 1992 352-358
5. M.H. Pittler E. Ernst Ginkgo biloba extract for the treatment of intermittent claudication: A meta-analysis of randomized trials Am J Med 108 2000 276-281
6. R.A. DeFronzo E. Ferrannini Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 1991 173-194
7. G.B. Kudolo The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic β-cell function in response to glucose loading in healthy volunteers J Clin Pharmacol 40 2000 647-654
8. G.B. Kudolo The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic β-cell function in response to glucose loading in individuals with non-insulin dependent diabetes mellitus J Clin Pharmacol 41 2001 600-611
9. G.B. Kudolo S. Dorsey J. Blodgett Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and type 2 diabetic subjects Throm Res 108 2003 151-160
10. 2 production in healthy subjects J Herbal Pharmacother 4 2004 13-26
11. G.B. Kudolo W. Wang S. Dorsey J. Blodgett Oral ingestion of Ginkgo biloba extract reduces thiobarbituric acid reacting (TBAR) substances in washed platelets of healthy subjects J Herbal Pharmacother 4 2003 1-15
12. G.B. Kudolo D. Delaney J. Blodgett Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects Diabetes Res Clin Pract 68 2005 29-38
13. S. Wild G. Roglic A. Green R. Sicree H. King Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047-1053
14. Tull SE, Roseman JM. Diabetes in African Americans. In: Diabetes in America, 2nd ed. National Institutes of Health. NIH Publications No. 95-1468, 1995. p. 613-630.
15. Stern MP, Mitchell BD. Diabetes in African Americans. In: Diabetes in America, 2nd ed. National Institutes of Health. NIH Publications No. 95-1468, 1995. p. 631-655.
16. A.L. Rosenbloom J.R. Joe R.S. Young W.E. Winter Emerging epidemic of type 2 diabetes in youth Diabetes Care 22 1999 345-354
17. X. Urrutia-Rojas J. Menchaca W. Wadley N. Ahmed A. Lacko S. Bae et. al. Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus (T2DM) J Adolesc Health 34 2004 290-299
18. R.A. DeFronzo Pathogenesis of type 2 diabetes mellitus Med Clin North Am 88 2004 787-835
19. American Diabetes Association: Clinical Practice Recommendation 2005 Diabetes Care 28 Suppl.1 2005 S4-S36
20. R.A. DeFronzo J.D. Tobin R. Andres Glucose clamp technique: A method for quantifying insulin action and resistance Am J Physiol 237 1979 E214-E223
21. R. Steele J.S. Wall R.C. de Bodo N. Altszuler Measurement of size and turnover rate of body glucose pool by the isotope dilution method Am J Physiol 187 1956 15-24
22. M.P. Diamond K. Thornton M. Connolly-Diamond R.S. Sherwin R.A. DeFronzo Reciprocal variations in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance J Soc Gynecol Investig 5 1995 708-715
23. M. Matsuda R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462-1470
24. Y. Miyazaki L. Glass C. Triplitt E. Wajcberg L.J. Mandarino R.A. DeFronzo Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus Am J Physiol Endocrinol Metab 283 2002 E1135-E1143
25. US Food and Drug Administration, Center for Food Safety and Applied Nutrition. http://www.cfsan.fda.gov/~dms/dietsupp.html.
26. S.H. Huang C. Jeng S.C. Kao J.J. Yu D.Z. Liu Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy Clin Nutr 23 2004 615-621
27. S.M. Haffner R.A. Valdez H.P. Hazuda B.D. Mitchell P.A. Morales M.P. Stern Prospective analysis of the insulin resistance syndrome (Syndrome X) Diabetes 41 1992 715-722
28. P.S. Denker V.E. Pollack Fasting serum insulin levels in essential hypertension. A meta-analysis Arch Intern Med 152 1992 1649-1651
29. L. Groop A. Ekstrand C. Forsblom E. Widen P.H. Groop A.M. Teppo et. al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin dependent) diabetes mellitus Diabetes/Metab Rev 4 1988 727-747
30. E. Ferrannini R.A. DeFronzo The association of hypertension, diabetes, and obesity. A review J Nephrol 1 1989 3-15
31. P. Braquet T.Y. Shen L. Touqui B.B. Vargraftig Perspectives in platelet-activating factor research Pharmacol Rev 39 1987 97-145
32. C.E. Mogensen Natural history of renal functional abnormalities in human diabetes mellitus: From normoalbuminuria to incipient and overt nephropathy B.M. Brenner J.H. Stein The Kidney in Diabetes Mellitus 1989 Churchill Livingstone New York 19-49
33. B. Lindahl K. Asplund M. Eliasson P.E. Evrin Insulin resistance and fibrinolytic activity: The northern Sweden MONICA study Int J Epidemiol 25 1996 291-299
34. S. Srivastava C.S. Joshi P.P. Sethi A.K. Agrawal S.K. Srivasta P.K. Seth Altered platelet functions in non-insulin dependent diabetes mellitus Throm Res 76 1994 451-461
35. S.D. Shukla P. Anjan D.M. Klachkot Hypersensitivity of diabetic human platelets to platelet-activating factor Throm Res 66 1992 239-246
36. J.R. Sowers M. Epstein Diabetes mellitus and associated hypertension, vascular disease and nephropathy. An update Hypertension 26 1995 869-879
37. H.J. Oskarsson T.G. Hofmeyer Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation J Am Coll Cardiol 27 1996 6-12
38. G.B. Kudolo R.A. DeFronzo Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus Prostagl Other Lipid Mediat 57 1999 87-98
39. G.B. Kudolo P. Bressler R.A. DeFronzo Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: Effect of hyperinsulinemia and lovastatin treatment J Lipid Mediat Cell Signal 17 1997 97-112
40. P. Gresele G. Guglielmini M. De Angelis S. Ciferri M. Ciofetta E. Falcinelli et. al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus J Am Coll Cardiol 19;41 2003 1013-1020
41. J.L. Witztum D. Steinberg Role of oxidized low density lipoprotein in atherogenesis J Clin Invest 88 1991 1785-1792
42. A. Sobol C. Watala The role of platelets in diabetes-related vascular complications Diabetes Res Clin Pract 50 Suppl 2001 1-16
43. D.R. Matthews J.P. Hosker A.S. Rudenski B.A. Naylor D.F. Treacher R.C. Turner Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412-419
44. R.A. DeFronzo Pharmacologic therapy for type 2 diabetes mellitus Ann Intern Med 13 1999 281-303